ONYX Pharmaceuticals, Inc.
(NASDAQ:ONXX)|
26.38 -1.72 (-6.12%) 12:45ET Delayed |
|
|
|
- Compare ONXX with:
- View: Line | Candlestick
Company Profile
ONYX Pharmaceuticals, Inc.
2100 Powell Street
Emeryville, CA 94608
United States - Map
Phone: (510) 597-6500
Fax: (510) 597-6600
Website: www.onyx-pharm.com
State of incorporation: Delaware
CEO: Dr. N. Anthony Coles, M.D.
Employees: 153
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Developer of therapeutics
A biopharmaceutical company which develops innovative therapies that target the molecular mechanisms that cause cancer.
Recent news for ONXX
-
Coughing Is Bad for Amgen's Health
Motley Fool - Nov 21 at 4:20 ET
-
[$$] Oversold Situation Must Still Be Resolved
RealMoney by TheStreet.com - Nov 21 at 8:30 ET
-
Reuters Summit-UPDATE - Amgen tumor-starving drug gets spotlight
Reuters - Nov 18 at 6:17 ET
-
ONYX PHARMACEUTICALS INC Financials
EDGAR Online Financials - Nov 13 at 9:04 ET
-
BTG Inks $320 Million Pre-clinical Deal With Onyx
Seeking Alpha - Nov 10 at 12:53 ET
-
New Star Analyst Rankings for ONYX PHARM INC
StarMine - Nov 09 at 9:19 ET
-
Onyx licenses British companys cancer drug
bizjournals.com - Nov 08 at 7:05 ET
-
Health Winners & Losers: Luminex
TheStreet.com - Nov 07 at 5:16 ET
-
Motley Fool - Nov 07 at 3:11 ET
-
Onyx Pharma Healthy with Nexavar
Zacks.com - Nov 07 at 1:04 ET
Top members owning ONXX
-
Top 5%
-45.82%3m:
-46.50%YTD:
-
Top 41%
-29.25%3m:
-30.45%YTD:
-
Top 55%
-36.29%3m:
-37.11%YTD: